Martin Shkreli, former CEO of Turing Pharmaceuticals, declined to answer questions Thursday before a House committee probing escalating drug costs. Shkreli repeatedly exercised his Fifth Amendment right against self-incrimination, which led to his dismissal from the hearing. Photo AP Subscribe to the WSJ channel here: More from the Wall Street Journal: Visit : Follow WSJ on Facebook: Follow WSJ on Google :
Hide player controls
Hide resume playing